Andrew Dreyfus insider trades

Open-market stock purchases and sales by Andrew Dreyfus, Director at Alto Neuroscience, Inc, from SEC Form 4 filings since Apr 6, 2016.

Recent trades

DateStockTradeValue
May 12, 2026ANRO Alto Neuroscience, IncBought (not open market)—

Companies traded

  • ANRO Alto Neuroscience, Inc: other filings, last May 12, 2026
  • IRWD Ironwood Pharmaceuticals Inc: other filings, last Jun 10, 2025

Get free alerts when Andrew Dreyfus files a new trade →